ATE266019T1 - Heteroaromatische carboxamid-derivate und ihre verwendung als hemmer des enzyms ikk-2 - Google Patents
Heteroaromatische carboxamid-derivate und ihre verwendung als hemmer des enzyms ikk-2Info
- Publication number
- ATE266019T1 ATE266019T1 AT01902951T AT01902951T ATE266019T1 AT E266019 T1 ATE266019 T1 AT E266019T1 AT 01902951 T AT01902951 T AT 01902951T AT 01902951 T AT01902951 T AT 01902951T AT E266019 T1 ATE266019 T1 AT E266019T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- carboxamide derivatives
- heteroaromatic carboxamide
- ikk
- enzyme
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- 229940053202 antiepileptics carboxamide derivative Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- -1 heteroaromatic carboxamides Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0003154.2A GB0003154D0 (en) | 2000-02-12 | 2000-02-12 | Novel compounds |
| PCT/SE2001/000248 WO2001058890A1 (en) | 2000-02-12 | 2001-02-07 | Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE266019T1 true ATE266019T1 (de) | 2004-05-15 |
Family
ID=9885396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01902951T ATE266019T1 (de) | 2000-02-12 | 2001-02-07 | Heteroaromatische carboxamid-derivate und ihre verwendung als hemmer des enzyms ikk-2 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7358376B2 (de) |
| EP (1) | EP1261600B1 (de) |
| JP (1) | JP4812999B2 (de) |
| KR (1) | KR100738165B1 (de) |
| CN (1) | CN1243747C (de) |
| AT (1) | ATE266019T1 (de) |
| AU (1) | AU781047B2 (de) |
| BR (1) | BR0108143A (de) |
| CA (1) | CA2396824C (de) |
| DE (1) | DE60103132T2 (de) |
| DK (1) | DK1261600T3 (de) |
| ES (1) | ES2218376T3 (de) |
| GB (1) | GB0003154D0 (de) |
| IL (2) | IL150482A0 (de) |
| MX (1) | MXPA02007734A (de) |
| NO (1) | NO327741B1 (de) |
| NZ (1) | NZ519947A (de) |
| PT (1) | PT1261600E (de) |
| TR (1) | TR200401962T4 (de) |
| WO (1) | WO2001058890A1 (de) |
| ZA (1) | ZA200205300B (de) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869956B2 (en) | 2000-10-03 | 2005-03-22 | Bristol-Myers Squibb Company | Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK) |
| EP1324759A4 (de) * | 2000-10-12 | 2004-05-12 | Smithkline Beecham Corp | Nf--g(k)b inhibitoren |
| ES2305125T3 (es) | 2000-10-26 | 2008-11-01 | Amgen Inc. | Agentes anti-inflamatorios. |
| PL364111A1 (en) * | 2001-02-01 | 2004-12-13 | Bristol-Myers Squibb Company | Methods of treating inflammatory and immune diseases using inhibitors of ikappab kinase (ikk) |
| US6881741B2 (en) * | 2001-06-11 | 2005-04-19 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
| US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| EP1444207A2 (de) * | 2001-09-19 | 2004-08-11 | Pharmacia Corporation | Substituierte pyrazolylverbindungen zur behandlung von entzündungen |
| ATE404550T1 (de) * | 2001-09-21 | 2008-08-15 | Smithkline Beecham Corp | Chemische verbindungen |
| EP1436265A4 (de) | 2001-09-27 | 2004-12-15 | Smithkline Beecham Corp | Chemische verbindungen |
| WO2003028731A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
| EP1448545B1 (de) * | 2001-10-04 | 2008-11-19 | Smithkline Beecham Corporation | Nf-kb-inhibitoren |
| JP2005509645A (ja) * | 2001-10-30 | 2005-04-14 | ファルマシア・コーポレーション | 炎症処置用のヘテロ芳香族カルボキサミド誘導体 |
| AR037641A1 (es) | 2001-12-05 | 2004-11-17 | Tularik Inc | Moduladores de inflamacion |
| DE60325051D1 (de) * | 2002-06-06 | 2009-01-15 | Boehringer Ingelheim Pharma | SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG |
| US6974870B2 (en) | 2002-06-06 | 2005-12-13 | Boehringer Ingelheim Phamaceuticals, Inc. | Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| US7375131B2 (en) | 2002-06-06 | 2008-05-20 | Smithklinebeecham Corp. | NF-κB inhibitors |
| US7179836B2 (en) | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
| WO2004041285A1 (en) | 2002-10-31 | 2004-05-21 | Amgen Inc. | Antiinflammation agents |
| US7196106B2 (en) | 2002-11-05 | 2007-03-27 | Merck & Co., Inc | Cyanothiophene derivatives, compositions containing such compounds and methods of use |
| AU2003300832A1 (en) * | 2002-12-06 | 2004-06-30 | Smithkline Beecham Corporation | NF-KappaB INHIBITORS |
| KR101058696B1 (ko) * | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
| SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
| DE602004017478D1 (de) | 2003-08-15 | 2008-12-11 | Astrazeneca Ab | Substituierte thiophene und deren verwendungen |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| CA2541667A1 (en) * | 2003-10-14 | 2005-04-21 | Pharmacia Corporation | Substituted pyrazinone compounds for the treatment of inflammation |
| WO2005037797A1 (en) * | 2003-10-21 | 2005-04-28 | Pharmacia Corporation | Substituted pyrazole urea compounds for the treatment of inflammation |
| ATE501138T1 (de) * | 2004-01-05 | 2011-03-15 | Astrazeneca Ab | Thiophenderivate als chk-1-inhibitoren |
| EP1764367A1 (de) * | 2004-04-12 | 2007-03-21 | Sankyo Company, Limited | Thienopyridinderivate |
| WO2005105777A1 (en) * | 2004-05-05 | 2005-11-10 | Pharmacia & Upjohn Company Llc | Substituted thiophene amide compounds for the treatment of inflammation |
| AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
| PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
| WO2006036031A1 (ja) * | 2004-09-30 | 2006-04-06 | Takeda Pharmaceutical Company Limited | 縮合フラン誘導体およびその用途 |
| JP5000490B2 (ja) | 2005-04-28 | 2012-08-15 | 武田薬品工業株式会社 | チエノピリミドン化合物 |
| AR055343A1 (es) | 2005-06-30 | 2007-08-22 | Smithkline Beecham Corp | Derivados de indolcarboxamida inhibidores de quinasas ikk2 |
| US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
| CA2653654A1 (en) | 2006-06-06 | 2007-12-21 | Boehringer Ingelheim International Gmbh | Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use |
| JP5290186B2 (ja) * | 2006-11-15 | 2013-09-18 | ヴァイロケム ファーマ インコーポレイテッド | フラビウイルス感染症の治療または予防用のチオフェン類似体 |
| JP5070067B2 (ja) * | 2007-01-15 | 2012-11-07 | 参天製薬株式会社 | ＩκＢキナーゼβ阻害活性を有する新規インドール誘導体 |
| PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
| GB0709031D0 (en) | 2007-05-10 | 2007-06-20 | Sareum Ltd | Pharmaceutical compounds |
| EP2278999B1 (de) | 2008-04-21 | 2025-01-29 | Dompé farmaceutici S.p.A. | Ohrbehandlungsformulierungen zur behandlung von ohrenerkrankungen und -leiden |
| US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
| CN102089281A (zh) | 2008-07-14 | 2011-06-08 | 参天制药株式会社 | 具有氨基甲酰基、脲基及取代氧基的新型吲哚衍生物 |
| JP2010077119A (ja) * | 2008-08-25 | 2010-04-08 | Santen Pharmaceut Co Ltd | ウレイド基、アミノカルボニル基及び置換フェニル基を置換基として有するピロール誘導体を有効成分として含有する骨・関節疾患の予防又は治療剤 |
| EP2319831A4 (de) * | 2008-08-25 | 2012-10-24 | Santen Pharmaceutical Co Ltd | Neuartiges pyrrolderivat mit einer ureidgruppe, einer aminocarbonylgruppe und einer eventuell mit einem substituenten ausgestatteten bizyklischen gruppe als substituenten |
| KR101693901B1 (ko) * | 2008-11-14 | 2017-01-06 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 비-수화가능한 결정 형태의 제조 방법 |
| WO2010102968A1 (en) | 2009-03-10 | 2010-09-16 | Glaxo Group Limited | Indole derivatives as ikk2 inhibitors |
| GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
| WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
| GB201016912D0 (en) | 2010-10-07 | 2010-11-24 | Astrazeneca Ab | Novel combination |
| JP2012176930A (ja) * | 2010-10-07 | 2012-09-13 | Santen Pharmaceut Co Ltd | ウレイド基とアミノカルボニル基を置換基として有するチオフェン誘導体を有効成分として含有する新規ｊａｋ３阻害剤 |
| GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
| GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
| EP2520292A1 (de) | 2011-05-06 | 2012-11-07 | Helmholtz-Zentrum für Infektionsforschung GmbH | Verwendung von Spirangienen zur Behandlung oder Prävention von IL-8- oder IL-6-vermittelten Erkrankungen |
| GB201202027D0 (en) | 2012-02-06 | 2012-03-21 | Sareum Ltd | Pharmaceutical compounds |
| EP3040336B1 (de) | 2012-03-02 | 2020-04-08 | Sareum Limited | Verbindungen zur verwendung in der behandlung von tyk2 kinase vermittelten erkrankungen |
| AU2017290256A1 (en) | 2016-06-29 | 2019-01-17 | Otonomy, Inc. | Triglyceride otic formulations and uses thereof |
| GB201617871D0 (en) | 2016-10-21 | 2016-12-07 | Sareum Limited | Pharmaceutical compounds |
| US11000491B2 (en) | 2017-05-05 | 2021-05-11 | Hepanova, Inc. | Amino-aryl-benzamide compounds and methods of use thereof |
| GB201816369D0 (en) | 2018-10-08 | 2018-11-28 | Sareum Ltd | Pharmaceutical compounds |
| GB202005114D0 (en) | 2020-04-07 | 2020-05-20 | Sareum Ltd | Crystalline Forms of a Pharmaceutical Compound |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1468012A (en) | 1973-08-09 | 1977-03-23 | Beecham Group Ltd | 2-amino-3-carboxy-thiophene derivatives |
| DE3529247A1 (de) | 1985-05-17 | 1986-11-20 | Bayer Ag, 5090 Leverkusen | Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung |
| US5258357A (en) * | 1989-10-07 | 1993-11-02 | Basf Aktiengesellschaft | Carboxamides, their preparation and their use as herbicides |
| US5378703A (en) * | 1990-04-09 | 1995-01-03 | Alcon Laboratories, Inc. | Sulfonamides useful as carbonic anhydrase inhibitors |
| US5571810A (en) * | 1990-06-11 | 1996-11-05 | Fujisawa Pharmaceutical Co., Ltd. | Thiophene derivatives |
| EP0912548A1 (de) * | 1996-07-11 | 1999-05-06 | Pfizer Inc. | Pyridylpyrrol-derivate verwendbar als interleukin- und tnf- antagonisten |
| PT853083E (pt) * | 1997-01-06 | 2001-12-28 | Pfizer | Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica |
| US6037340A (en) | 1997-05-28 | 2000-03-14 | Cadus Pharmaceutical Corporation | Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds |
| DE19744026A1 (de) * | 1997-10-06 | 1999-04-08 | Hoechst Marion Roussel De Gmbh | Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| WO1999046244A1 (en) | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| HN2000000051A (es) | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
| US6414013B1 (en) | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| EP1324759A4 (de) * | 2000-10-12 | 2004-05-12 | Smithkline Beecham Corp | Nf--g(k)b inhibitoren |
| US20040024047A1 (en) * | 2001-10-12 | 2004-02-05 | Callahan James F. | Nf-kb inhibitors |
| SE0102617D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
| EP1448545B1 (de) * | 2001-10-04 | 2008-11-19 | Smithkline Beecham Corporation | Nf-kb-inhibitoren |
| SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
-
2000
- 2000-02-12 GB GBGB0003154.2A patent/GB0003154D0/en not_active Ceased
-
2001
- 2001-02-07 TR TR2004/01962T patent/TR200401962T4/xx unknown
- 2001-02-07 AT AT01902951T patent/ATE266019T1/de active
- 2001-02-07 ES ES01902951T patent/ES2218376T3/es not_active Expired - Lifetime
- 2001-02-07 PT PT01902951T patent/PT1261600E/pt unknown
- 2001-02-07 MX MXPA02007734A patent/MXPA02007734A/es active IP Right Grant
- 2001-02-07 KR KR1020027010124A patent/KR100738165B1/ko not_active Expired - Fee Related
- 2001-02-07 WO PCT/SE2001/000248 patent/WO2001058890A1/en not_active Ceased
- 2001-02-07 DK DK01902951T patent/DK1261600T3/da active
- 2001-02-07 IL IL15048201A patent/IL150482A0/xx active IP Right Grant
- 2001-02-07 JP JP2001558440A patent/JP4812999B2/ja not_active Expired - Fee Related
- 2001-02-07 AU AU30705/01A patent/AU781047B2/en not_active Ceased
- 2001-02-07 CA CA2396824A patent/CA2396824C/en not_active Expired - Fee Related
- 2001-02-07 BR BR0108143-8A patent/BR0108143A/pt not_active Application Discontinuation
- 2001-02-07 US US09/868,884 patent/US7358376B2/en not_active Expired - Fee Related
- 2001-02-07 NZ NZ519947A patent/NZ519947A/en not_active IP Right Cessation
- 2001-02-07 CN CNB018046606A patent/CN1243747C/zh not_active Expired - Fee Related
- 2001-02-07 DE DE60103132T patent/DE60103132T2/de not_active Expired - Lifetime
- 2001-02-07 EP EP01902951A patent/EP1261600B1/de not_active Expired - Lifetime
-
2002
- 2002-06-27 IL IL150482A patent/IL150482A/en not_active IP Right Cessation
- 2002-07-02 ZA ZA200205300A patent/ZA200205300B/en unknown
- 2002-08-09 NO NO20023786A patent/NO327741B1/no not_active IP Right Cessation
-
2007
- 2007-12-03 US US11/949,273 patent/US20090181962A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ519947A (en) | 2004-05-28 |
| CA2396824C (en) | 2010-11-16 |
| US20090181962A1 (en) | 2009-07-16 |
| KR100738165B1 (ko) | 2007-07-10 |
| DK1261600T3 (da) | 2004-08-16 |
| DE60103132D1 (de) | 2004-06-09 |
| AU781047B2 (en) | 2005-05-05 |
| AU3070501A (en) | 2001-08-20 |
| ZA200205300B (en) | 2003-10-02 |
| MXPA02007734A (es) | 2002-10-11 |
| US7358376B2 (en) | 2008-04-15 |
| NO20023786L (no) | 2002-09-23 |
| TR200401962T4 (tr) | 2004-09-21 |
| DE60103132T2 (de) | 2005-05-12 |
| PT1261600E (pt) | 2004-08-31 |
| KR20030005183A (ko) | 2003-01-17 |
| JP2003522766A (ja) | 2003-07-29 |
| WO2001058890A1 (en) | 2001-08-16 |
| JP4812999B2 (ja) | 2011-11-09 |
| CN1243747C (zh) | 2006-03-01 |
| NO327741B1 (no) | 2009-09-14 |
| BR0108143A (pt) | 2003-01-21 |
| EP1261600A1 (de) | 2002-12-04 |
| IL150482A (en) | 2006-08-01 |
| NO20023786D0 (no) | 2002-08-09 |
| CA2396824A1 (en) | 2001-08-16 |
| US20020107252A1 (en) | 2002-08-08 |
| ES2218376T3 (es) | 2004-11-16 |
| GB0003154D0 (en) | 2000-04-05 |
| CN1425012A (zh) | 2003-06-18 |
| IL150482A0 (en) | 2002-12-01 |
| EP1261600B1 (de) | 2004-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60103132D1 (de) | Heteroaromatische carboxamid-derivate und ihre verwendung als hemmer des enzyms ikk-2 | |
| IL160028A0 (en) | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions containing them and their use in therapy | |
| CY1107817T1 (el) | Καρβοξαμιδια θειοφαινιου ως αναστολεις του ενζυμου ικκ-2 | |
| MXPA04000755A (es) | Nuevos compuestos. | |
| CY1111086T1 (el) | Παραγωγα 2-αμινο-κιναζολινης χρησιμα ως αναστολεις της βητα-σεκρετασης (bace) | |
| ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| MXPA03008754A (es) | Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor. | |
| TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
| DE50202504D1 (de) | Neue 4-aminofuropyrimidine und ihre verwendung | |
| DE602004005016D1 (de) | Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren | |
| MXPA05010875A (es) | Derivados de piperazina como inhibidores de renina. | |
| SE0300092D0 (sv) | Novel compounds | |
| MY134026A (en) | ?-carboline derivatives and its pharmaceutical use against depression and anxiety | |
| MXPA04004981A (es) | Derivados de piperazina para uso como antagonistas del receptor ccr-3 en tratamiento de asma. | |
| ATE373636T1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
| MXPA03003466A (es) | Derivados de piranosido. | |
| TR199902097A2 (xx) | Mikrobial transformasyon. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1261600 Country of ref document: EP |